Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Co-Diagnostics, Inc. Fourth Quarter and Full Year 2022 Earnings Results Conference Call. All participants will be in a listen-only mode.
Stay updated with breaking news from Biofire Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good afternoon, and welcome to the Co-Diagnostics, Inc. Fourth Quarter and Full Year 2022 Earnings Results Conference Call. All participants will be in a listen-only mode.
Case counts, age distribution, and clinical characteristics were compared for January 1, 2016, to December 31, 2019; January 1, 2020, to December 31, 2021 (pandemic period); and October 1 to December 31, 2022.
The company's test uses qPCR to measure the expression of two genes to determine the probability of sepsis.
The Business Research Company's COVID-19 Detection Test Kits And Consumables Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032
The rising incidence of infectious bacterial and viral diseases impacts the market's demand because, in the syndromic testing, multiplex real-time PCR...